STOCK TITAN

Zimmer Biomet (ZBH) director Arthur Higgins receives new stock and phantom unit grants

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zimmer Biomet director Arthur J. Higgins received new equity-based compensation awards. He was granted 1,517.274 Restricted Stock Units tied to common stock, bringing his Restricted Stock Unit holdings to 26,382 units. He also received 875.350 Phantom Stock Units under the Deferred Compensation Plan, increasing his phantom unit balance to 37,357.322 units.

The phantom units have a 1-for-1 conversion ratio into common stock and are to be settled in shares within sixty days after he ceases serving as a director. The Restricted Stock Units are immediately 100% vested but are subject to mandatory deferral until the later of his termination of service as a director or three years after the grant date, and include prior-year grants with different deferral periods.

Positive

  • None.

Negative

  • None.
Insider HIGGINS ARTHUR J
Role Director
Type Security Shares Price Value
Grant/Award Phantom Stock Units 875.35 $0.00 $0.00
Grant/Award Restricted Stock Units 1,517.274 $0.00 $0.00
Holdings After Transaction: Phantom Stock Units — 37,357.322 shares (Direct); Restricted Stock Units — 26,382 shares (Direct)
Footnotes (6)
  1. F1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  2. F2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
  3. F3. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  4. F4. Includes 106.777 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  5. F5. The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
  6. F6. Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Restricted Stock Units granted 1,517.274 units Grant on May 22, 2026
RSU holdings after grant 26,382.000 units Total Restricted Stock Units following transaction
Phantom Stock Units granted 875.350 units Accrued on May 22, 2026 under director plan
Phantom units after grant 37,357.322 units Total Phantom Stock Units following transaction
Conversion ratio 1-for-1 Phantom units convert 1-for-1 into common stock
Phantom DRIP addition 106.777 units Accrued April 30, 2026 via dividend reinvestment
Deferred Compensation Plan for Non-Employee Directors financial
"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
phantom stock units financial
"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
Restricted Stock Units financial
"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
mandatory deferral financial
"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date."
dividend reinvestment provision financial
"Includes 106.777 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
A dividend reinvestment provision is a company policy that lets shareholders automatically use their cash dividends to buy more shares instead of receiving money. Think of it like a subscription that turns each payday into buying an extra slice of the same pie; it helps investors compound their holdings over time, often with lower transaction costs and sometimes at a small discount, which can boost long‑term returns and subtly change ownership percentages.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did ZIMMER BIOMET (ZBH) director Arthur J. Higgins report?

Arthur J. Higgins reported receiving equity awards, not open-market trades. He was granted 1,517.274 Restricted Stock Units and 875.350 Phantom Stock Units, both linked to Zimmer Biomet common stock as part of his director compensation structure.

How many Restricted Stock Units did Arthur J. Higgins hold after the latest ZBH grant?

After the latest grant, Arthur J. Higgins held 26,382 Restricted Stock Units. These units are immediately 100% vested but must be deferred until the later of his board service ending or three years after the grant, according to the plan’s deferral rules.

What are Phantom Stock Units in the ZIMMER BIOMET (ZBH) director plan?

Phantom Stock Units are bookkeeping units that track Zimmer Biomet’s stock value. Higgins’ units were accrued under the Deferred Compensation Plan for Non-Employee Directors and convert 1-for-1 into common shares, generally settled within sixty days after his service as a director ends.

How many Phantom Stock Units does Arthur J. Higgins now have at ZBH?

Following the reported award, Arthur J. Higgins holds 37,357.322 Phantom Stock Units. This balance includes 875.350 new units, plus previously accrued units and 106.777 units added earlier through the plan’s dividend reinvestment provision for non-employee directors.

When will Arthur J. Higgins’ Phantom Stock Units at ZIMMER BIOMET be settled?

His Phantom Stock Units are scheduled to be settled in Zimmer Biomet common stock within sixty days after he ceases serving as a director. Until then, they remain as deferred units under the company’s Deferred Compensation Plan for Non-Employee Directors.

Are Arthur J. Higgins’ new Restricted Stock Units at ZBH immediately vested?

Yes, the newly granted Restricted Stock Units are immediately 100% vested. However, they are subject to mandatory deferral until the later of his termination of service as a director or three years after the grant date, plus older grants with different deferral periods.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HIGGINS ARTHUR J

(Last)(First)(Middle)
345 E. MAIN STREET

(Street)
WARSAW INDIANA 46580

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Phantom Stock Units(1)$85.68(2)05/22/2026A875.35 (3) (3)Common Stock875.35$037,357.322(4)D
Restricted Stock Units(2)05/22/2026A1,517.274 (5) (5)Common Stock1,517.274$026,382(6)D
Explanation of Responses:
1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
4. Includes 106.777 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
5. The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
6. Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
/s/ Matthew R. St. Louis, Attorney-in-Fact for Arthur J. Higgins (power of attorney previously filed)05/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)